Logo image of SOL

EMEREN GROUP LTD (SOL) Stock Fundamental Analysis

NYSE:SOL - New York Stock Exchange, Inc. - US75971T3014 - ADR - Currency: USD

1.69  -0.16 (-8.65%)

After market: 1.68 -0.01 (-0.59%)

Fundamental Rating

3

Taking everything into account, SOL scores 3 out of 10 in our fundamental rating. SOL was compared to 51 industry peers in the Construction & Engineering industry. While SOL seems to be doing ok healthwise, there are quite some concerns on its profitability. SOL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SOL has reported negative net income.
In the past year SOL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SOL reported negative net income in multiple years.
SOL had a negative operating cash flow in each of the past 5 years.
SOL Yearly Net Income VS EBIT VS OCF VS FCFSOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

SOL has a Return On Assets of -1.08%. This is in the lower half of the industry: SOL underperforms 70.59% of its industry peers.
The Return On Equity of SOL (-1.65%) is worse than 70.59% of its industry peers.
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROIC N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
SOL Yearly ROA, ROE, ROICSOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

SOL's Gross Margin of 26.87% is fine compared to the rest of the industry. SOL outperforms 78.43% of its industry peers.
In the last couple of years the Gross Margin of SOL has declined.
The Profit Margin and Operating Margin are not available for SOL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
SOL Yearly Profit, Operating, Gross MarginsSOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

5

2. Health

2.1 Basic Checks

SOL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SOL has been reduced compared to 1 year ago.
The number of shares outstanding for SOL has been increased compared to 5 years ago.
Compared to 1 year ago, SOL has a worse debt to assets ratio.
SOL Yearly Shares OutstandingSOL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SOL Yearly Total Debt VS Total AssetsSOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SOL has an Altman-Z score of -0.49. This is a bad value and indicates that SOL is not financially healthy and even has some risk of bankruptcy.
SOL has a worse Altman-Z score (-0.49) than 90.20% of its industry peers.
SOL has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.17, SOL is doing good in the industry, outperforming 74.51% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -0.49
ROIC/WACCN/A
WACC9.82%
SOL Yearly LT Debt VS Equity VS FCFSOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

SOL has a Current Ratio of 4.03. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SOL (4.03) is better than 100.00% of its industry peers.
SOL has a Quick Ratio of 4.03. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.03, SOL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4.03
SOL Yearly Current Assets VS Current LiabilitesSOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.54% over the past year.
SOL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.25%.
SOL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.02% yearly.
EPS 1Y (TTM)61.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.5%
Revenue 1Y (TTM)-20.25%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-44.86%

3.2 Future

The Earnings Per Share is expected to grow by 72.80% on average over the next years. This is a very strong growth
Based on estimates for the next years, SOL will show a quite strong growth in Revenue. The Revenue will grow by 11.79% on average per year.
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOL Yearly Revenue VS EstimatesSOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SOL Yearly EPS VS EstimatesSOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SOL. In the last year negative earnings were reported.
SOL is valuated reasonably with a Price/Forward Earnings ratio of 8.16.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SOL indicates a rather cheap valuation: SOL is cheaper than 98.04% of the companies listed in the same industry.
SOL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
Industry RankSector Rank
PE N/A
Fwd PE 8.16
SOL Price Earnings VS Forward Price EarningsSOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

SOL's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.64
SOL Per share dataSOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

SOL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SOL's earnings are expected to grow with 72.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SOL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMEREN GROUP LTD

NYSE:SOL (5/29/2025, 8:14:36 PM)

After market: 1.68 -0.01 (-0.59%)

1.69

-0.16 (-8.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-18 2025-08-18/amc
Inst Owners45.15%
Inst Owner Change-2.6%
Ins Owners1.06%
Ins Owner Change0%
Market Cap86.73M
Analysts80
Price Target4.59 (171.6%)
Short Float %24.27%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-92.82%
Min EPS beat(2)-384.65%
Max EPS beat(2)199.01%
EPS beat(4)2
Avg EPS beat(4)-67.17%
Min EPS beat(4)-384.65%
Max EPS beat(4)199.01%
EPS beat(8)3
Avg EPS beat(8)-824.63%
EPS beat(12)4
Avg EPS beat(12)-552.14%
EPS beat(16)6
Avg EPS beat(16)-418.14%
Revenue beat(2)0
Avg Revenue beat(2)-27.74%
Min Revenue beat(2)-40.72%
Max Revenue beat(2)-14.76%
Revenue beat(4)1
Avg Revenue beat(4)-16.47%
Min Revenue beat(4)-51.47%
Max Revenue beat(4)41.07%
Revenue beat(8)2
Avg Revenue beat(8)-16.8%
Revenue beat(12)3
Avg Revenue beat(12)-22.58%
Revenue beat(16)3
Avg Revenue beat(16)-24.91%
PT rev (1m)0%
PT rev (3m)-10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-112.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-90.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-26.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-41.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.16
P/S 1.01
P/FCF N/A
P/OCF 143.84
P/B 0.29
P/tB 0.29
EV/EBITDA 23.64
EPS(TTM)-0.1
EYN/A
EPS(NY)0.21
Fwd EY12.25%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.01
OCFY0.7%
SpS1.67
BVpS5.92
TBVpS5.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -1.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.87%
FCFM N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
F-Score5
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 13.21
Cap/Depr 213.85%
Cap/Sales 18.16%
Interest Coverage N/A
Cash Conversion 15.52%
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4.03
Altman-Z -0.49
F-Score5
WACC9.82%
ROIC/WACCN/A
Cap/Depr(3y)305.97%
Cap/Depr(5y)240.17%
Cap/Sales(3y)29.54%
Cap/Sales(5y)22.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.5%
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.25%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-44.86%
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.27%
OCF growth 3YN/A
OCF growth 5YN/A